← All trials
NCT01767909
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 8, 2014
- Primary completion
- Dec 31, 2018
- Completion date
- Dec 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Southern CaliforniaLead sponsor
- Wake Forest UniversityStudy director
- University of Southern CaliforniaStudy director
- National Institute on Aging (NIA)Collaborator
- Alzheimer's Therapeutic Research InstituteCollaborator
- Wake Forest UniversityCollaborator
- University of Southern CaliforniaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.